Kimberly-Clark is set to report its second-quarter results later this month, and analysts are forecasting a double-digit drop ...

Clark, and Target continue to deliver disappointing results. Stock prices at multiyear lows reflect investor frustrations.

Kimberly-Clark's cost-saving plans aim for $200M in SG&A by 2027, boosted by global tissue market growth. Find out why KMB is ...

Kimberly-Clark, a dividend king with reliable brands, offers a 3.9% yield but faces valuation and growth challenges. See why ...

Kimberly-Clark Co. has a twelve month low of $124.10 and a twelve month high of $150.45. The company has a current ratio of 0.80, a quick ratio of 0.54 and a debt-to-equity ratio of 7.05.

Kimberly-Clark Stock Performance Shares of NYSE:KMB opened at $128.93 on Wednesday. The firm has a market capitalization of $42.78 billion, a PE ratio of 17.08, a P/E/G ratio of 4.46 and a beta of ...

Moreover, shares of Kimberly-Clark have dipped 1.3% over the past 52 weeks, compared to XLP’s 5.1% return over the same time frame. The stock has fallen below its 50-day and 200-day moving ...

Suzano S.A. SUZ and Kimberly-Clark Corporation KMB announced that they would create a $3.4-billion joint venture that will manufacture consumer and professional tissue products.

The stock has fallen below its 50-day and 200-day moving averages since June. Despite Kimberly-Clark beating Q1 2025 earnings expectations with an adjusted EPS of $1.93, shares fell 1.5% on Apr. 22.